Japan Chronic Disease Trends: Cancer and Dementia in an Ageing Society

National Cancer Center Hospital East
File photo: the National Cancer Center Hospital East, Kashiwa, Chiba. Photo: Abasaa via Wikimedia Commons, public domain.
Rates down, numbers highUpdated 5 October 2026

Trend summary

  • Japan is the world’s oldest major society, so chronic disease dominates its death figures. Age for age, death rates keep falling, but the number of older people living with diabetes and dementia keeps rising.
  • 1,589,533 people died in Japan in 2025, the first fall in five years, down 15,845 from the record 1,605,378 of 2024 (Ministry of Health, Labour and Welfare (MHLW), final figures, 30 September 2026).
  • Cancer remains the leading cause, with 378,829 deaths (23.8%), followed by heart disease (220,539) and senility (老衰, rōsui) at 214,712, which rose again and is close to overtaking heart disease.
  • About 11 million adults are strongly suspected of having diabetes, the highest figure yet, according to the 2024 National Health and Nutrition Survey.
1,589,533deaths from all causes, Japan, 2025 (final), first fall in five years
378,829cancer deaths, Japan, 2025, 23.8% of all deaths
~11 millionadults strongly suspected of having diabetes, Japan, 2024 survey
4.43 millionpeople aged 65+ estimated to have dementia, Japan, 2022

What the numbers show

The main source is MHLW’s vital statistics (人口動態統計, jinkō dōtai tōkei), the count of every birth and death registered in Japan. A provisional annual total (概数, gaisū) comes out each June and the final figures (確定数, kakuteisū) each September. The final 2025 figures (in Japanese), published on 30 September 2026, record 1,589,533 deaths, almost the same as the provisional 1,589,489 released in June. Cancer caused 378,829 deaths, heart disease (excluding hypertensive heart disease) 220,539, senility 214,712 and stroke and other cerebrovascular disease 100,361. Alzheimer’s disease (25,769) and vascular and other dementia (23,905) were both in the top ten. Deaths from cancer, heart disease and stroke all fell from 2024, while senility rose by 7,825. Age-adjusted death rates fell to 13.9 per 1,000 for men and 7.7 for women, from 14.2 and 7.8, so the high totals reflect an older population rather than rising risk. MHLW’s 2025 life tables (in Japanese) put life expectancy at 81.35 years for men and 87.33 for women. Lower death rates from cancer and heart disease were among the main reasons it went up.

The figures for people living with disease are larger. The 2024 National Health and Nutrition Survey (国民健康・栄養調査, in Japanese), carried out in October and November 2024, estimates that about 11 million adults are strongly suspected of having diabetes. That figure has risen in every survey since 1997. About 7 million more cannot be ruled out, a group that has shrunk since 2007. The national cancer registry counted 993,469 new cancer diagnoses in 2023 (in Japanese), about the same as 2022. The National Cancer Center’s cancer statistics (in Japanese) give a five-year relative survival of 64.8% for people diagnosed in 2018. A 2024 MHLW-funded study estimated that 4.43 million people aged 65 and over had dementia in 2022 (12.3%, in Japanese), plus 5.59 million with mild cognitive impairment, and projected 5.84 million with dementia by 2040. The 2023 Patient Survey (in Japanese) estimated 22.1 million people under treatment for circulatory diseases such as high blood pressure, the largest disease group.

What is driving it

Ageing is the main driver. As more people live into their late 80s and 90s, more deaths are recorded as senility, pneumonia or dementia, and fewer as the cancers and heart attacks that killed people younger. This is why total deaths reached a record in 2024 even as age-adjusted rates fell. Lifestyle risks are mixed. The 2024 survey found average salt intake of 9.6 g a day, the lowest in twelve years but still well above the Health Japan 21 target of 7 g. It also found that 14.8% of adults smoke regularly, matching the lowest level in that period.

Policy works through national plans. The fourth Basic Plan to Promote Cancer Control and a revised cardiovascular disease plan were adopted in March 2023. The Health Japan 21 (third term) programme, which runs from 2024, caps the number of people with diabetes at 13.5 million. The first Basic Plan for the Promotion of Dementia Policy, made under the 2024 Dementia Basic Act, was adopted by the Cabinet on 3 December 2024. In July 2026 MHLW published a mid-term evaluation of the cancer plan (in Japanese).

The trend, 2015–2025

0100k200k300k400k20152016201720182019202020212022385,797202320242025378,829
Deaths from cancer (malignant neoplasms), Japan, final counts
YearDeathsChange on year before
2015370,346–
2016372,986+0.7%
2017373,334+0.1%
2018373,584+0.1%
2019376,425+0.8%
2020378,385+0.5%
2021381,505+0.8%
2022385,797+1.1%
2023382,504−0.9%
2024384,111+0.4%
2025378,829−1.4%

Notes: All years are final counts for Japanese nationals in Japan. Raw counts are pushed up by population ageing; age-adjusted rates are the better guide to whether risk is falling.

Source: MHLW, Vital Statistics final data (2015–2025 editions)

Common questions

Are cancer deaths in Japan going up or down?

In 2025 the figure was 378,829 deaths. That is 2.3% higher than in 2015 (370,346) and 1.4% down on 2024.

Which year was highest and which was lowest?

In this 2015–2025 series the highest year was 2022 (385,797) and the lowest was 2015 (370,346).

Why do cancer deaths stay so high in Japan?

Mainly because the population is ageing and cancer risk rises steeply with age. Raw deaths peaked at 385,797 in 2022 and were 378,829 in 2025. Age-adjusted rates show more clearly whether the risk for a person of a given age is falling.

Policy and budget changes

The main government measures and money figures behind this risk, newest first. Each item links to the official text we checked; where only a news report was available, the source says so.

Main policy changes

  • 3 December 2024 First Basic Plan for Dementia Policy adopted. The Cabinet adopted the first Basic Plan for the Promotion of Dementia Policy under the Dementia Basic Act. It sets four priority goals, and prefectures and municipalities are asked to make their own plans. (MHLW)
  • 1 January 2024 Dementia Basic Act comes into force. The Basic Act on Dementia to Promote an Inclusive Society came into force, setting out national and local government duties on dementia policy. (MHLW)
  • 31 May 2023 Health Japan 21 (third term) published. The health ministry published the third term of Health Japan 21, the national health promotion programme, as Ministerial Notice No. 207. It sets national targets for lifestyle-related diseases and their risk factors. (MHLW)
  • 28 March 2023 Fourth Basic Plan to Promote Cancer Control adopted. The Cabinet adopted the fourth Basic Plan to Promote Cancer Control, the national plan for cancer prevention, screening, treatment and support. (MHLW)
  • 1 April 2020 Indoor smoking restrictions take full effect. The Act Partially Amending the Health Promotion Act (Act No. 78 of 2018), which restricts smoking indoors to prevent unwanted second-hand smoke, came fully into force. (MHLW)

Budget and costs

  • December 2025 Cancer control budget: ¥34.1bn for FY2026. The health ministry’s FY2026 budget plan (December 2025) allocates ¥34.1 billion to cancer control, against ¥34.2 billion in FY2025, with a further ¥7.1 billion in the FY2025 supplementary budget for items such as evidence-based screening and the national cancer registry. (Ministry of Health, Labour and Welfare)
  • December 2025 Dementia measures: ¥12.5bn, unchanged. The Health and Welfare Bureau for the Elderly’s FY2026 budget plan allocates ¥12.5 billion to comprehensive dementia measures, the same as in FY2025, including ¥1.3 billion for dementia medical centres and ¥1.3 billion for research. (Ministry of Health, Labour and Welfare)

Recent cases

  • 30 September 2026: MHLW’s final 2025 vital statistics confirm 1,589,533 deaths, the first fall in five years. Senility (214,712 deaths) rises again while cancer, heart disease and stroke deaths all fall (MHLW, in Japanese).
  • 24 July 2026: the 2025 abridged life tables put life expectancy at 81.35 years for men and 87.33 for women. MHLW says falling death rates from cancer and heart disease helped lengthen lives, while pneumonia and senility worked the other way (MHLW, in Japanese).
  • 3 June 2026: provisional 2025 figures show 1,589,489 deaths, 15,889 fewer than in 2024, with cancer still the leading cause (MHLW, in Japanese).

Our read: what the numbers add up to

Put together, these figures describe a country where dying is becoming less likely at any given age, while the number of deaths stays close to its peak. The 1,589,533 deaths of 2025 were the first fall in five years, but only a modest step down from the record 1,605,378 of 2024, and I would not read it as a turning point. The more reliable signal is the age-adjusted death rate, which slipped to 13.9 per 1,000 for men and 7.7 for women. Underlying mortality is still improving; the totals are high because the population is old.

The cause-of-death table tells the same story from another angle. Cancer, heart disease and stroke deaths all fell from 2024, while senility rose by 7,825 to 214,712 and is now close to overtaking heart disease. The cost of that success shows up among the living rather than the dead: about 11 million adults strongly suspected of having diabetes, a figure that has risen in every survey since 1997, and 4.43 million older people estimated to have dementia in 2022.

There are limits to what can be inferred. Senility as a recorded cause probably depends partly on how doctors certify deaths among the very old, so its rise is not a pure measure of disease. The dementia estimate comes from a single study, and the diabetes figure from a survey rather than a register. What I would watch next is whether the diabetes count drifts towards the Health Japan 21 cap of 13.5 million, and whether the projection of 5.84 million people with dementia by 2040 starts to look early or late. My bottom line: Japan is not getting sicker age for age, but it is ageing faster than its health gains can hide.

Press releases and official reports, 2023–2026

Five key releases a year for the last four years, newest first. Most come from Japanese government ministries and agencies, regulators, accident investigators and national statistics; a few news reports are included where they are the clearest public record of an event. Many official releases are published only in Japanese; for those we give an English translation of the title and mark the link (in Japanese). Releases from 2007–2022 are in the expandable list after 2023.

2026

2025

2024

2023

View 20 years of major Japanese chronic disease press releases (2007–2026)69 more from 2007–2022, up to five a year, newest first

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Some early years list fewer than five items. Many older Japanese government releases are no longer online at their original addresses, and we only list items we could find and check.

Photo list

University of Tokyo Hospital
File photo: the University of Tokyo Hospital. Photo: Abasaa via Wikimedia Commons, public domain.
Wrist blood pressure monitor
File photo: a home blood pressure monitor. Photo: Marvelousola01 via Wikimedia Commons, CC0.

How this page is built. Figures come from the official statistical releases linked above; where agencies publish provisional numbers we say so, because they are revised. Japanese statistics often use the fiscal year (April to March) and some are published only in Japanese, so we say which period each figure covers and translate titles. Photos are public-domain or Creative Commons images credited in each caption; file photos are illustrative and are not from the events described unless the caption says so. This page tracks trends and is not personal safety, medical, legal or financial advice.